Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

Why Novavax Stock Is Skyrocketing Today

TheMotleyFool

0 0

Why Novavax Stock Is Skyrocketing TodayPhoto, wide shot, wide-angle lens, Clinical research organization, sunset photo at golden hour, photo by Peter Lik: https://img.midjourneyapi.xyz/temp/02f7778c-d723-4fb3-bdef-fabb7e5fc9c8.png

Shares of Novavax (NASDAQ: NVAX), a clinical-stage vaccine company, are poised to continue their amazing run today. The biotech's stock is already up by a noteworthy 20% in pre-market action Tuesday morning.

Novavax's shares are heating up yet again this morning in response to the official start of the combined phase 1/2 trial for the company's COVID-19 vaccine candidate, NVX‑CoV2373. Data from the phase 1 portion of the trial is expected to be released as soon as this July.

Image source: Getty Images.

Source Fool.com

Like: 0

NVAX

Teilen